"10.1371_journal.pone.0144825","plos one","2015-12-28T00:00:00Z","Nibedita Chattopadhyay; Allison J Berger; Erik Koenig; Bret Bannerman; James Garnsey; Hugues Bernard; Paul Hales; Angel Maldonado Lopez; Yu Yang; Jill Donelan; Kristen Jordan; Stephen Tirrell; Bradley Stringer; Cindy Xia; Greg Hather; Katherine Galvin; Mark Manfredi; Nelson Rhodes; Ben Amidon","Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America; Metabolon Inc, Durham, North Carolina, United States of America","Conceived and designed the experiments: NC EK AJB ST BS BA. Performed the experiments: NC EK BB JG HB PH AML YY CX NR. Analyzed the data: NC EK NR BA GH. Contributed reagents/materials/analysis tools: JD KJ. Wrote the paper: NC. Overall concept: KG MM.","This study was funded by Takeda Pharmaceuticals International Co. Authors NC, AJB, EK, BB, JG, HB, PH, AML, YY, JD, KJ, ST, BS, CX, GK, MM, and BA are employed by Takeda Pharmaceuticals. NR is employed by Metabolon Inc. Patent information: A patent application on portions of this work has been filed (WO2013071142 A1) under the title Biomarkers of response to proteasome inhibitors by Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","12","Nibedita Chattopadhyay","NC",19,TRUE,6,10,5,1,TRUE,TRUE,FALSE,0,NA,FALSE
